Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro.

about

Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro.

Item

http://www.wikidata.org/entity/Q47133536

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@en

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@nl

type

Item

label

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@en

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@nl

prefLabel

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@en

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@nl

P1476

Unfractionated heparin protect ...... d damage in vivo and in vitro.

@en

P2093

Dongmei Zhao

http://www.w3.org/2001/XMLSchema#string

Renyu Ding

http://www.w3.org/2001/XMLSchema#string

Xiaochun Ma

http://www.w3.org/2001/XMLSchema#string

Xiaohan Yin

http://www.w3.org/2001/XMLSchema#string

Yina Liu

http://www.w3.org/2001/XMLSchema#string

Zhidan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients

Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Metalloproteolytic release of endothelial cell protein C receptor

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

The immunopathogenesis of sepsis

The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.

Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis.

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.

P304

5515-5522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5236

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285085

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

5740512

http://www.w3.org/2001/XMLSchema#string